CD95 Ligand expression enhances growth of murine renal cell carcinoma in vivo

Citation
H. Nishimatsu et al., CD95 Ligand expression enhances growth of murine renal cell carcinoma in vivo, CANCER IMMU, 48(1), 1999, pp. 56-61
Citations number
15
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER IMMUNOLOGY IMMUNOTHERAPY
ISSN journal
03407004 → ACNP
Volume
48
Issue
1
Year of publication
1999
Pages
56 - 61
Database
ISI
SICI code
0340-7004(199904)48:1<56:CLEEGO>2.0.ZU;2-2
Abstract
The CD95/CD95 ligand (CD95L)system plays an important role in the induction of lymphoid apoptosis and has been implicated in the suppression of immune responses. In this system, two murine CD95L-transfected renca clones and a control renca clone transfected only with the vector were implanted into t he subcapsule of the left kidney of Balb/c and Balb/c nude mice. Both CD95L -expressing and control renca clones formed macroscopic tumors in all of th e Balb/c and Balb/c nude hosts 14 days after implantation. Growth of tumors of murine CD95L-transfected renca cells was significantly better than that of control renca cells in Balb/c mice, while the growth advantage of CD95L transfectants was not observed in Balb/c nude mice. Lymphocytes underwent apoptosis mainly in the periphery of the CD95L-expressing tumors but not in control tumors grown in Balb/c mice, while lymphocytes undergoing apoptosi s were not observed in CD95L-expressing tumors or in control tumors grown i n Balb/c nude mice. Neutrophilic recruitment was rarely observed in CD95L-e xpressing or control tumors. CD95L ex; pressed on renca cells possibly supp ressed immune responses against renca tumors by inducing apoptosis of the i nfiltrating lymphocytes. However, CD95L-expressing renca cells did not form tumors in the renal subcapsule of allogeneic C3H/HeJ mice.